ENvue Medical Inc
FEED
5 hedge funds and large institutions have $18.1K invested in ENvue Medical Inc in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
25% more funds holding
Funds holding: 4 → 5 (+1)
0.18% less ownership
Funds ownership: 0.25% → 0.08% (-0.18%)
73% less capital invested
Capital invested by funds: $67.5K → $18.1K (-$49.4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$25.5K |
| 2 |
Citigroup
New York
|
+$7.45K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$37.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $12.7K | +$25.5K | +854 | +166% |
|
|
2
Citigroup
New York
| $2.32K | +$7.45K | +250 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $2.1K | +$3.7K | +124 | +122% |
|
|
4
Morgan Stanley
New York
| $954 | -$37.5K | -1,259 | -92% |
|
5
Bank of America
Charlotte,
North Carolina
| $6 | – | – | – |
|
6
Fidelity Investments
Boston,
Massachusetts
| $1 | – | – | – |
|
|
SS
7
SBI Securities
Tokyo,
Japan
| $1 | – | – | – |
|
FEED Hedge Fund Activity: Q2 2025 in Review
5 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q2 2025, worth a combined $18.1K — down 73% from $67.5K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new FEED positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $25.5K. The largest seller was Morgan Stanley, cutting an estimated $37.5K.
- 5 institutional investors held ENvue Medical Inc (FEED) as of Q2 2025, up from 4 in Q1 2025.
- Funds reported $18.1K of ENvue Medical Inc stock for Q2 2025, down 73% quarter-over-quarter.
- 1 fund opened new ENvue Medical Inc positions in Q2 2025 and 0 closed out, a net change of +1 holder.
- The largest ENvue Medical Inc buyer in Q2 2025 was UBS Group, an estimated $25.5K added.
- The largest ENvue Medical Inc seller in Q2 2025 was Morgan Stanley, an estimated $37.5K sold.
Based on aggregated 13F filings for Q2 2025.